치료저항성 정신분열병 환자에서 반복적 경두개자기자극술 병행치료시 혈장 BDNF 농도 변화 : 예비 연구

키워드

참고문헌 (43)

1. Thoenen H, "Neurotrophins and neuronal plasticity", Science, 270, pp.593~598 (1995)
2. Mattson MP, "Glutamate and neurotrophic factors in neuronal plasticity and disease", Ann N Y Acad Sci, 1144, pp.97~112 (2008)
3. Pillai A, "Brain-derived neurotropic factor", TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia, 2008, pp.16, 183~193
4. Angelucci F, "BDNF in schizophrenia, depression and corresponding animal models", Mol Psychiatry, 10, pp.345~352 (2005)
5. Marenco S, "The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave", Dev Psychopathol, 12, pp.501~527 (2000)
6. Knable MB, "Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium", Mol Psychiatry, 9, pp.609~620 (2004)
7. Russo-Neustadt A, "Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders", Semin Clin Neuropsychiatry, 8, pp.109~118 (2003)
8. Martinowich K, "Interaction between BDNF and serotonin: role in mood disorders", Neuropsychopharmacology, 33, pp.73~83 (2008)
9. Durany N, "Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses", Schizophr Res, 52, pp.79~86 (2001)
10. Iritani S, "Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains", Prog Neuropsychopharmacol Biol Psychiatry, 27, pp.801~807 (2003)
11. Toyooka K, "Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients", Psychiatry Res, 110, pp.249~257 (2002)
12. Tan YL, "Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics", Neurosci Lett, 382, pp.27~32 (2005)
13. Pirildar S, "Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment", Prog Neuropsychopharmacol Biol Psychiatry, 28, pp.709~713 (2004)
14. Buckley PF, "Brain derived neurotropic factor in first-episode psychosis", Schizophr Res, 91, pp.1~5 (2007)
15. Shimizu E, "Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls", Neurosci Lett, 351, pp.111~114 (2003)
16. Lee BH, "Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment", Neuropsychobiology, 59, pp.51~58 (2009)
17. Yoshimura R, "Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.1072~1077 (2007)
18. Brunelin J, "Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia", Schizophr Res, 81, pp.41~45 (2006)
19. Chibbaro G, "Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations", Neurosci Lett, 383, pp.54~57 (2005)
20. d'Alfonso AA, "Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition", J Neuropsychiatry Clin Neurosci, 14, pp.77~79 (2002)
21. Hoffman RE, "Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices"", Biol Psychiatry, 46, pp.130~132 (1999)
22. Hoffman RE, "Transcranial magnetic stimulation and auditory hallucinations in schizophrenia", Lancet, 355, pp.1073~1075 (2000)
23. Hoffman RE, "Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample", Biol Psychiatry, 58, pp.97~104 (2005)
24. Hoffman RE, "Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations", Arch Gen Psychiatry, 60, pp.45~56 (2003)
25. Horacek J, "Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations", Neuropsychobiology, 55, pp.132~142 (2007)
26. Poulet E, "Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia", Biol Psychiatry, 57, pp.188~191 (2005)
27. Chen R, "Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation", Neurology, 48, pp.1398~1403 (1997)
28. Hajak G, "High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study", Psychol Med, 34, pp.1157~1163 (2004)
29. Rollnik JD, "Repetitive transcranial magnetic stimulation and electroconvulsive therapy in a patient with treatment-resistant schizoaffective disorder", Depress Anxiety, 13, pp.103~104 (2001)
30. Sachdev P, "Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation", Psychiatry Clin Neurosci, 59, pp.354~357 (2005)
31. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders. 4th ed" (2000), American Psychiatric Association
32. Kane J, "Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine", Arch Gen Psychiatry, 45, pp.789~796 (1988)
33. Falkai P, "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia", World J Biol Psychiatry, 6, pp.132~191 (2005)
34. Lehman AF, "Practice guideline for the treatment of patients with schizophrenia, second edition", Am J Psychiatry, 161, pp.1~56 (2004)
35. Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
36. 김용구, "한국어판 정신분열병의 캘거리 우울증 척도의 신뢰도 및 타당도 연구", 신경정신의학, 44(4), pp.446~455 (2005), 대한신경정신의학회
37. Montagne-Larmurier A, "Two-day treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: A 6 month follow-up pilot study", Schizophr Res (2009)
38. Lang UE, "Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: no effects on brain-derived neurotrophic factor (BDNF) concentrations in serum", J Affect Disord, 107, pp.255~258 (2008)
39. Lang UE, "Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation", Psychopharmacology (Berl), 187, pp.56~59 (2006)
40. Yukimasa T, "High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors", Pharmacopsychiatry, 39, pp.52~59 (2006)
41. Zanardini R, "Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients", J Affect Disord, 91, pp.83~86 (2006)
42. Okamoto T, "Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.1185~1190 (2008)
43. Hori H, "Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients", Int Clin Psychopharmacol, 22, pp.21~27 (2007)

관련 논문AI추천